Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q4	-- / 198.695B	--
Feb 14, 2025	2025/Q3	-- / 206.323B	--
Nov 14, 2024	2025/Q2	201.020B / 202.409B	--
Aug 14, 2024	2025/Q1	194.565B / 195.019B	--
May 15, 2024	2024/Q4	185.805B / 186.572B	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q4-- / 198.695B--

Feb 14, 20252025/Q3-- / 206.323B--

Nov 14, 20242025/Q2201.020B / 202.409B--

Aug 14, 20242025/Q1194.565B / 195.019B--

May 15, 20242024/Q4185.805B / 186.572B--

Unlock Free Earnings Estimates

Open Account

Sundrug: Confirmatory letter.

Nov 14 01:44 ET

Sundrug: Semi-Annual Report - Term 62 (2024/04/01 - 2025/03/31)

Nov 14 01:41 ET

Sundrug: 2nd Half (Mid-Term) Decision SMS for March 2025 [Japan Basis] (link)

Nov 14 01:30 ET

Sundrug: 1st quarter financial results for the March 2025 period (consolidated) based on Japanese standards.

Aug 14 02:00 ET

Symbol Price % Chg

See the daily top gainer.

Analysis

Updated: Dec 5, 2024

Buy

No Data